Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Aged 3-5 Months: A Phase 3 Clinical Trial

Trial Profile

Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Aged 3-5 Months: A Phase 3 Clinical Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Hib-meningococcal vaccine groups A and C conjugate (Primary) ; Hib vaccine; Meningococcal vaccine groups A and C polysaccharide
  • Indications Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 24 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top